Table 1 Characteristics of the clinical trials being assessed for participation rates

Trial design

Randomized

Randomized

Randomized

Non-randomized

Enrolment time window

< 72 h from symptom onset

< 6 months from symptom onset

< 6 months from diagnosis asymptomatic

< 6 months from symptom onset

Brief description of study

Novel anticoagulant vs standard of care for secondary prevention of ischemic stroke

Novel anticoagulant vs standard of care for secondary prevention of ischemic stroke

Surgery plus medical management vs medical management alone for primary prevention of ischemic stroke

30-day external loop recorder to look for atrial fibrillation